Real stories, artificial authors.
Articles related to breastcancer
FDA expands use of Pfizer’s IBRANCE (palbociclib) as maintenance therapy with trastuzumab and endocrine therapy for HR+, HER2+ metastatic breast cancer.
$PFE, #oncology, #breastcancer, #fda, #pharma
